Heterologous expression of active human uridine diphosphate glucuronosyltransferase 1A3 in Chinese hamster lung cells

World Journal of Gastroenterology

Volumn 11, Issue 1, 2005, Pages 118-121

  Chen, Ya Kun ^a   Li, Xin ^a   Chen, Shu Qing ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Lung; Uridine diphosphate glucuronosyltransferase 1A3

Indexed keywords

BETA GLUCURONIDASE; CALCIUM PHOSPHATE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A3; MESSENGER RNA; NEOMYCIN; QUERCETIN; RNA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANTENNA; ARTICLE; CELL CULTURE; CHINESE HAMSTER; CONTROLLED STUDY; DNA SEQUENCE; DRUG GLUCURONIDATION; EXPRESSION VECTOR; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSFECTION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN TISSUE; HYDROLYSIS; LIVER; LUNG ALVEOLUS CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 11844298342     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i1.118     Document Type: Article

References (32)

1. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000; 40: 581-616
2. Gong QH, Cho JW, Huang T. Thirteen UDP glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001; 11: 357-368
3. Kurkela M, Garcia-Horsman JA, Luukkanen L. Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 2003; 278: 3536-3544
4. Kuehl GE, Murphy SE. N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. Drug Metab Dispos 2003; 31: 1361-1368
5. Nakajima M, Tanaka E, Kobayashi T, Ohashi N, Kume T, Yokoi T. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms. Drug Metab Dispos 2002; 30: 636-642
6. Linnet K. Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes. Hum Psychopharmacol 2002; 17: 233-238
7. Breyer-Pfaff U, Mey U, Green MD, Tephly TR. Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes. Drug Metab Dispos 2000; 28: 869-872
8. Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 1998; 26: 507-512
9. Sabolovic N, Magdalou J, Netter P, Abid A. Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. Life Sci 2000; 67: 185-196
10. Ghosal A, Hapangama N, Yuan Y. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos 2004; 32: 314-320
11. De Leon J. Glucuronidation enzymes, genes and psychiatry. Int J Neuropsychopharmacol 2003; 6: 57-72
12. Francoual J, Trioche P, Mokrani C. Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP). Prenat Diagn 2002; 22: 914-916
13. Wells PG, Mackenzie PI, Chowdhury JR. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 2004; 32: 281-290
14. Tricker AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2003; 183: 151-173
15. Cummings J, Ethell BT, Jardine L. Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. Cancer Res 2003; 63: 8443-8450
16. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003; 3 136-158
17. Duguay Y, McGrath M, Lepine J. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 2004; 64: 1202-1207
18. Li X, Yu Y, Zhu G, Qian Y. Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells. World J Gastroenterol 2001; 7: 841-845
19. Iwai M, Maruo Y, Ito M, Yamamoto K, Sato H, Takeuchi Y. Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 2004; 49: 123-128
20. Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 2004; 74: 2769-2779
21. Hu YZ, Yao TW. In vitro metabolism and inductive or inhibitive effect of DL111 on rat cytochrome P4501A enzyme. Chem Biol Interact 2004; 147: 109-117
22. Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol 2004; 57: 287-297
23. Fujita K, Mogami A, Hayashi A, Kamataki T. Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). Life Sci 2000; 66: 1955-1967
24. Coffman BL, Kearney WR, Green MD, Lowery RG, Tephly TR. Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy. Mol Pharmacol 2001; 59: 1464-1469
25. Goto A, Adachi Y, Inaba A, Nakajima H, Kobayashi H, Sakai K. Identification of human p450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its inhibitory effect on enzyme activity. Biol Pharm Bull 2004; 27: 684-690
26. Kaku T, Ogura K, Nishiyama T, Ohnuma T, Muro K, Hiratsuka A. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4. Biochem Pharmacol 2004; 67: 2093-2102
27. Turgeon D, Chouinard S, Belanger P, Picard S, Labbe JF, Borgeat P, Belanger A. Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 2003; 44: 1182-1191
28. Cuff RL, Wade LT, Rychlik B, Jedlitschky GA, Burchell B. Characterisation of glucuronidation and transport in V79 cells co-expressing UGT1A1 and MRP1. Toxicol Lett 2001; 120: 43-49
29. Jinno H, Saeki M, Saito Y, Tanaka-Kagawa T, Hanioka N, Sai K, Kaniwa N, Ando M, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Ozawa S, Sawada J. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. J Pharmacol Exp Ther 2003; 306: 688-693
30. Milane HA, Ubeaud G, Vandamme TF, Jung L. Isolation of quercetin's salts and studies of their physicochemical properties and antioxidant relationships. Bioorg Med Chem 2004; 12: 3627-3635
31. Hollman PC, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 1997; 51: 305-310
32. Day AJ, Bao Y, Morgan MR, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 2000; 29: 1234-1243